excedrin extra strength pain reliever

Generic: acetaminophen, aspirin (nsaid), and caffeine

Labeler: navajo manufacturing company inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name excedrin extra strength pain reliever
Generic Name acetaminophen, aspirin (nsaid), and caffeine
Labeler navajo manufacturing company inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1

Manufacturer
Navajo Manufacturing Company Inc.

Identifiers & Regulatory

Product NDC 67751-119
Product ID 67751-119_239668fa-359b-fe6e-e063-6394a90a98af
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2019-03-15

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc] central nervous system stimulant [epc] methylxanthine [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs] xanthines [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 67751119
Hyphenated Format 67751-119

Supplemental Identifiers

RxCUI
209468 308297
UNII
362O9ITL9D R16CO5Y76E 3G6A5W338E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832 N0000175739 N0000175729 N0000175790 M0023046

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name excedrin extra strength pain reliever (source: ndc)
Generic Name acetaminophen, aspirin (nsaid), and caffeine (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
  • 65 mg/1
source: ndc
Packaging
  • 1 POUCH in 1 CARTON (67751-119-01) / 2 TABLET, FILM COATED in 1 POUCH
  • 2 POUCH in 1 CARTON (67751-119-02) / 2 TABLET, FILM COATED in 1 POUCH
source: ndc

Packages (2)

67751-119-01 1 POUCH in 1 CARTON (67751-119-01) / 2 TABLET, FILM COATED in 1 POUCH 67751-119-02 2 POUCH in 1 CARTON (67751-119-02) / 2 TABLET, FILM COATED in 1 POUCH

Ingredients (3)

acetaminophen (250 mg/1) aspirin (250 mg/1) caffeine (65 mg/1)

Linked Drug Pages (1)

Excedrin Extra Strength Pain Reliever ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "239668fa-359b-fe6e-e063-6394a90a98af", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["209468", "308297"], "spl_set_id": ["f7e572e9-82a7-2127-e053-6394a90ab01a"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Navajo Manufacturing Company Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (67751-119-01)  / 2 TABLET, FILM COATED in 1 POUCH", "package_ndc": "67751-119-01", "marketing_start_date": "20190315"}, {"sample": false, "description": "2 POUCH in 1 CARTON (67751-119-02)  / 2 TABLET, FILM COATED in 1 POUCH", "package_ndc": "67751-119-02", "marketing_start_date": "20190315"}], "brand_name": "Excedrin Extra Strength Pain Reliever", "product_id": "67751-119_239668fa-359b-fe6e-e063-6394a90a98af", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "67751-119", "generic_name": "Acetaminophen, Aspirin (NSAID), and Caffeine", "labeler_name": "Navajo Manufacturing Company Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Excedrin", "brand_name_suffix": "Extra Strength Pain Reliever", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190315", "listing_expiration_date": "20261231"}